Spire Healthcare Group (LON:SPI)‘s stock had its “buy” rating reiterated by stock analysts at Peel Hunt in a note issued to investors on Wednesday, ThisIsMoney.Co.Uk reports.
A number of other research analysts have also weighed in on the company. Royal Bank of Canada lowered Spire Healthcare Group to a “sector performer” rating and set a GBX 100 ($1.23) target price for the company. in a report on Monday, May 11th. Liberum Capital restated a “hold” rating on shares of Spire Healthcare Group in a research report on Tuesday, April 7th. Two analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of GBX 126.29 ($1.55).
Shares of SPI opened at GBX 85.10 ($1.05) on Wednesday. The business has a 50-day moving average of GBX 93.11 and a 200 day moving average of GBX 108.46. Spire Healthcare Group has a fifty-two week low of GBX 51.10 ($0.63) and a fifty-two week high of GBX 145 ($1.78). The firm has a market cap of $341.32 million and a P/E ratio of 47.28. The company has a debt-to-equity ratio of 124.33, a quick ratio of 0.77 and a current ratio of 1.03.
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Recommended Story: Initial Coin Offerings entail a high degree of risk
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.